Wegovy: MHRA approves higher dose for obese patients

Credit: PA Wire/James Manning

By Daniel Pye

Obese patients can be prescribed up to 7.2mg dose of semaglutide (Wegovy) following approval by the medicines regulator.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved the new maximum dose for those who have a BMI of 30kg/m² or higher.